PharmaSGP Holding SE (PSG.DE)

EUR 23.8

(1.71%)

Operating Expenses Summary of PharmaSGP Holding SE

PharmaSGP Holding SE's latest annual operating expenses in 2023 was 50.72 Million EUR , down -15.06% from previous year.
PharmaSGP Holding SE's latest quarterly operating expenses in 2024 Q2 was 19.71 Million EUR , up 16.2% from previous quarter.
PharmaSGP Holding SE reported a annual operating expenses of 59.1 Million EUR in annual operating expenses 2022, up 36.31% from previous year.
PharmaSGP Holding SE reported a annual operating expenses of 43.36 Million EUR in annual operating expenses 2021, up 5.85% from previous year.
PharmaSGP Holding SE reported a quarterly operating expenses of 19.71 Million EUR for 2024 Q2, up 16.2% from previous quarter.
PharmaSGP Holding SE reported a quarterly operating expenses of 17.26 Million EUR for 2023 Q2, up 1.36% from previous quarter.

Annual Operating Expenses Chart of PharmaSGP Holding SE (2023 - 2017)

Historical Annual Operating Expenses of PharmaSGP Holding SE (2023 - 2017)

Year	Operating Expenses	Operating Expenses Growth
2023	50.72 Million EUR	-15.06%
2022	59.1 Million EUR	36.31%
2021	43.36 Million EUR	5.85%
2020	40.96 Million EUR	27.13%
2019	32.22 Million EUR	4.12%
2018	30.94 Million EUR	3.16%
2017	30 Million EUR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	16.96 Million EUR	46.68%
2024 Q2	19.71 Million EUR	16.2%
2023 Q2	17.26 Million EUR	1.36%
2023 Q1	17.03 Million EUR	13.61%
2023 FY	50.2 Million EUR	-15.06%
2023 Q4	11.56 Million EUR	-30.46%
2023 Q3	16.62 Million EUR	-3.68%
2022 Q4	14.99 Million EUR	8.38%
2022 Q3	13.83 Million EUR	-6.32%
2022 Q2	14.76 Million EUR	-4.82%
2022 Q1	15.51 Million EUR	24.22%
2022 FY	59.1 Million EUR	36.31%
2021 Q1	9.69 Million EUR	-8.8%
2021 Q4	12.49 Million EUR	1.08%
2021 Q3	12.35 Million EUR	40.09%
2021 FY	43.36 Million EUR	5.85%
2021 Q2	8.82 Million EUR	-9.02%
2020 Q2	9.19 Million EUR	-18.02%
2020 FY	40.96 Million EUR	27.13%
2020 Q4	10.63 Million EUR	7.08%
2020 Q3	9.92 Million EUR	8.02%
2020 Q1	11.21 Million EUR	116.51%
2019 Q1	9.59 Million EUR	0.0%
2019 FY	32.22 Million EUR	4.12%
2019 Q4	5.17 Million EUR	-31.63%
2019 Q3	7.57 Million EUR	-23.31%
2019 Q2	9.87 Million EUR	2.99%
2018 FY	30.94 Million EUR	3.16%
2017 FY	30 Million EUR	0.0%

Peer Operating Expenses Comparison of PharmaSGP Holding SE

Name	Operating Expenses	Operating Expenses Difference
MPH Health Care AG	4.22 Million EUR	-1101.518%
Apontis Pharma AG	23.17 Million EUR	-118.912%
Dermapharm Holding SE	142.51 Million EUR	64.408%
Evotec SE	222.55 Million EUR	77.209%
MERCK Kommanditgesellschaft auf Aktien	8.82 Billion EUR	99.425%
SynBiotic SE	1.5 Million EUR	-3267.127%